Alzheimer's disease (AD) is the most prominent dementia-related disease and characterized by the presence of insoluble amyloid beta peptide (Aβ) fibers in or around the brain neurons of the affected person. Therefore, agent(s) capable of inhibiting brain amyloid deposition might delay the occurrence or retard the progress forwards of AD and related neurobehavioral symptoms.
Introduction
The pathological hallmarks of Alzheimer disease (AD) brain include amyloid neuritic plaques and neurofibrillar tangles, concurrently with progressive loss of neurons and memory-related learning ability of the patients [1] . Once it is cleaved and released from membrane-bound amyloid precursor protein (APP), amyloid beta peptide (Aβ) transforms into insoluble amyloid fibers and deposits in the brains of the affected persons [2] [3] . The predominant amyloid species found in the deposits of AD brains are Aβ and Aβ . It is thus conceivable that learning-related memory impairments could also be induced by the infusion of these short stretches of Aβ and Aβ peptides into the cerebral ventricle of rats [4] [5] [6] . In this investigation, we infused Aβ into rat ventricles and prepared the AD model rats. AD is also an age-related neurodegenerative disease and associated with decline in memory-related learning ability [7] [8] . Numerous research conducted on AD over the past several decades have concentrated on oxidative stress and its impacts on the pathogenesis [9] . The free radicals cause oxidation of lipids [10] [11] , proteins [12] [13] and DNA/RNA [14] [15] of the neurons, which become very vulnerable to death in AD. In this regard, it is thus plausible that antioxidant therapy would provide an important beneficial effect on the memory decline of AD patients. Accordingly, several studies have focused that vitamin E attenuates the toxic effects of amyloid peptide and improves cognitive performance, with a concurrent suppression of lipid peroxidation [16] - [22] .
S. cumini is a seasonal fruit of Bangladesh and can act as a rich source of antioxidative and radical scavenging phytoconstituents [23] . The seeds of this fruit retain extraordinary medicinal properties, which have remained largely undiscovered. The genus Syzygium is one of the genera of the myrtle family Myrtaceae. Plants of this family have a rich history of uses both as edibles and as traditional medicines in divergent ethnobotanical practices throughout the tropical and subtropical world [24] [25] . The plants have beneficial effects on digestive disorders, diuresis [26] , enteric disorders [27] and diarrhoea [28] .
Since unknown time, Syzygium is also used as traditional medicine in numerous ailments, such as cough, dysenteria, ringworm, piles, pimples and liver tonic [25] [29] . We have previously reported that S. cumini seed powder possesses anti-diabetic activity [30] and protects the liver against the lipid peroxidation with a concurrent amelioration of hepatocellular anatomical disintigrity
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DOI: 10.4236/aad.2017. 63005 55 Advances in Alzheimer's Disease of alcoholic rats [31] . S. cumini seed extract also exhibited stronger in vitro radical scavenging activity than that of the artificial antioxidant, such as butylatedhydroxy toluene (BHT). Furthermore, the oral administration of S. cumini seed extract restored the oxidative stress in the brain cerebral cortex of alcoholic rats [32] . We have also reported that S. cumini seed extract protects embryofoetal brains against intrauterine oxidative toxicity in rats during hypoxia-reperfusion injury [33] . Recently, we also have also reported that S. cumini seed extract improves memory-related lerarning ability of old rats [34] .
In all of these contexts [23] - [34] , there is substantial evidence to support the view that S. cumini extract might also have positive effects on the Alzheimer's disease, which is frequently seen associated with increased oxidative stress.
Accordingly, we pre-administered the rats with S. cumini extract and infused Aβ 1-40 into rat brain ventricles to generate AD model rats. Afterwards, we evaluated whether the oral administration of S. cumini extract affects the memory-impairments of AD model rats. We also determined if the levels of important neuronal proteins, such as, brain-derived neurotrophic factor (BDNF), tyrosine kinase B (TrkB), post-synaptic density protein (PSD-95) and synapse-associated protein-25 (SNAP-25), essential for the maintenance of brain cognition and learning-related memory ability of the AD model rats, are affected by the oral administration of S. cumini seed extract.
Materials and Methods
Syzygium cumini (Jam) was purchased from local market. Their seeds were separated, sun-dried and powdered by grinding. The grinded seed powder was extracted by using methanol (Figure 1 ). After evaporation by rotary evaporator, the extract was suspended in distilled water and orally administered to rats and/or used in in vitro studies.
Animals and Diet
Twenty male Wistar rats (50-weeks-old) were purchased and housed in a room under controlled temperature (23˚C ± 2˚C), relative humidity (50% ± 10%) and light-dark cycles (light: 08:00 to 20:00 h: dark: 20:00 to 08:00 h), and provided with a standard pellet diet. Then they were randomly divided into 2 groups: weeks of oral pre-administration, the rats from both groups were subjected to surgical procedures to generate AD model rats ( Figure 2 ). After complete recovery from surgical stress they were subjected to eight-arm radial maze task (for memory test) and extract feeding was continued (for another 5 weeks) until the end of behavioral experiments.
Surgery
The rats were anaesthetized lightly with sodium pentobarbital (50 mg/kg BW i.p.). Before surgery, the hair of the skull was removed; the skin above the skull was fissured by using a surgical blade in aseptic condition. The rats were then placed in the sterotaxis frame and the Bregma was first identified. The surgical techniques used were essentially the same as those described previously by Ha- ) is completed, the holes of the skull are closed by bone-cement. 12: After stitching, the rats are kept at 37˚C in the hotplate incubator. 13: Incision has been recovered (healed) after surgery. 14: The skull's condition after 5 -7-days of surgery, indicating a complete recovery from surgery. [36] with slight modification. After complete recovery from surgery, the AD model rats were fed either with saline or S. cumini extract (Figure 3 ).
Behavioral Analysis

Adaptation Trials of the Rats
The animals were habituated with the experimenter and radial maze (once per day for 7 days prior to the memory experiment). An eight-arm radial maze used for the estimation of learning ability and set at 60 cm elevation above floor level, consisted of an octagonal center platform surrounded by eight equally spaced radial arms (50 cm long and 11 cm wide). Food cups, 1.5 cm deep and 2.5 cm in diameter, were located at the end of each arm. Then, for five days, the rats were familiarized with the apparatus, where the reward pellets were scattered through-out the maze. In this way, the rats were habituated to explore the reward (food pellet) placed in food cups at the end of the radial arm.
Data Collection for Learning Ability
After familiarization of the 8-arm maze, the rats were subjected to test trials, as previously described [37] . A trial consisted of baiting only four arms with reward pellet and placing the rat in the center platform facing a randomly selected arm.
Here, the same four arms were baited consistently for any one animal. The testing continued for five weeks and involved two parameters of memory function: reference memory error (RME), entry into unbaited arms; and working memory error (WME), repeated entry into arms that had already been visited within a trial. A 5 minutes trial to collect the pellets was allowed for each rat. The experimenter maintained a constant position beside the maze and observed the behavior of the rats.
Brain Tissue Preparation
After the behavioral studies for memory evaluation were completed, the rats were anesthetized with sodium pentobarbital (65 mg/kg BW, i.p.) to collect blood, and the hippocampus and cerebral cortex were separated on ice as described previously [37] . Tissues were either first stored at −80˚C or immediately homogenized in ice-cold 0.32 M sucrose buffer (pH 7.4) containing 2 mM EDTA, and 0.2 mM phenylmethylsufonyl fluoride using a Polytron homogenizer (PCU 2-110; Kinematica GmbH, Steinhofhale, Switzerland). The homogenates were also centrifuged to prepare cytosolic fraction, which was stored at −80˚C until analyses were performed.
Lipid Peroxide (LPO) Assay
The oxidative stress in the plasma and brain tissues was evaluated by determining the levels of lipid peroxide (LPO). LPO was determined by estimating the thiobarbituric acid reactive substances (TBARs) according to the method Hashimoto et al., (2002) [4] . The samples (plasma and/or whole homogenate, 0.1 ml) were added to 0.1 ml of 8.1% (w/v) sodium dodecylsulphate, 2 ml of 0.4% thiobarbituric acid in 20% acetic acid (pH 3.5) and 0.1 ml distilled water. Each tube was tightly capped and heated at 95˚C for one hour. After cooling, 2 ml of n-butanol-pyridine (15:1, v/v) was added to tube and shaken vigorously for about 10 min. The tubes were then centrifuged at 1200 ×g for 10 min at room temperature (Digital centrifuge; DSC-1512SD). The absorbance of the supernatant fraction was measured at 532 nm. TEP (1,1,3,3-tetraethoxypropane) was utilized as standard. The levels of LPO were expressed as nmol/mg of protein.
ELISA for Aβ1-40 and Aβ1-40 Oligomers
The levels of 
TNFα, PSD-95, SNAP-25, BDNF and TrkB Assay
The levels of TNFα, PSD-95, SNAP-25, BDNF and TrkB proteins were determined by using indirect ELISA as previously described [39] . In brief, the multiwell plates were coated with 50 μg of cytosolic protein in a volume of 100 μl/well of carbonate buffer (pH 9.6) and incubated overnight at 4˚C. After three washes, the wells were blocked with 1% BSA in Tris-buffered saline (TBS) at room temperature for 1 h. Following three washes with TBS, primary anti-TNFα-antibody, primary anti-PSD-95 antibody, primary anti-SNAP-25 antibody, primary anti-BDNF antibody and primary anti-TrkB antibody, each of which was diluted at a ratio of 1:1000, were added to respective wells and incubated at 4˚C overnight.
Again, after three washes with TBS, the plates were incubated with 100 μl of HRP-conjugated anti-rabbit secondary antibody for 1 h at room temperature.
After final three washes with TBS, the color was developed with tetramethylbenzidine for 30 min and the reaction was stopped with HCl, and absorbance was 
In Vitro Anti-LPO (Lipid Peroxide) Study
The brain tissues from normal old rats were homogenized in phosphate buffer The reaction mixtures were then incubated at room temperature for 4 hours. At the end of incubation, the levels of LPO were determined as described above for those of the plasma [4] .
In Vitro Free Radical Scavenging Activity of S. cumini Seed Extract
Antioxdative power of the S. cumini seed extract also was analyzed by its DPPH radical scavenging activity, as described previously [40] . Briefly, the antioxidant activity of the extract was studied at several concentrations (0 -1.0 mM GAE, gallic acid equivalent). Aliquots of DPPH solution in ethanol (0.4 mM, 100 μl) and each extract solution (100 μl) or standard solutions of BHT (0 -1.0 mM, 100 μl) and quercetin (0 -1.0 mM, 100 μl) were mixed in the wells of 96-well plate.
The plate was then sealed, shaken for 10 s and placed in the dark for 30 min. Afterwards, the plate was carried out at room temperature, again shaken for 10 s, and then absorbance was taken at 515 nm. Data were reported as the average of three measurements. The IC 50 value was expressed as the concentration of extract or standards (BHT and quercetin) required to decrease the absorbance of DPPH (0.2 mM, final concentration) by 50%. The value can be determined graphically by plotting the absorbance against the used extract or standard concentrations.
In addition, to directly visualize the antioxidant activity of the extract, aliquots of 8 μl 0.4 mM DPPH solution were subjected to thin layer chromatographic (TLC) plate. After air drying, 8 μl of the extract and standards (BHT and quercetin) were re-applied onto the DPPH spots. After 30 min of incubation, the spots were photographed and analyzed by Image J.
Total Polyphenol/Flavonoid Contents of S. cumini Extract
To estimate total polyphenol content of S. cumini extract gallic acid was used as standard, as described previously by Hossain et al. (2012) [32] . Briefly, the calibration curve was generated using different concentrations of gallic acid (0 -0.2 mM) in the reaction mixture of Folin-Ciocalteu's reagent (FCR) in total volume 200 μl in micro well plate. These solutions were incubated at room temperature for 40 min. The absorbance was recorded at 710 nm using ELISA plate reader. Total polyphenol content was expressed as μmol of gallic acid equivalents per 100 mg of dry powder (GAE/100 mg of dry powder). Total flavonoid content of the S. cumini extract was estimated following aluminum chloride colorimetric assay described by Chang et al. (2001) [41] . Quercetin was used as standard. Total flavonoid content was expressed as μmol of quercetin equivalents per 100 mg of dry powder (μmol of QE/100 mg of dry powder).
Statistical Analysis
Results were expressed as mean ± SEM (standard error of means). Behavioral 
Results
Effects of S. cumini Administration on the BW of Aβ-Infused AD Model Rats
No significant differences were observed in body weight or food intake, measured after 12 wks, between Control (Aβ 1-40 + Vehicle-administered) and S. cumini seed extract-administered AD model rats (P < 0.05). The body weight of Aβ 1-40 infused rats was increased to the extent of 139% as compared to 135.5%
increase in weight of Aβ 1-40 + S. cumini seed extract-administered rats. Average daily food intake in Control was 15.60 gm/rat and in S. cumini seed extract rats was 16.13 gm/rat. 
Effects of S. cumini Administration on the Memory of Aβ-Infused AD Model Rats
Effects of S. cumini Administration on the Plasma and Brain LPO of AD Model Rats
The levels of LPO significantly decreased by ~28% in the plasma of the S. cumini-fed (Aβ 1-40 + S. cumini) rats, when compared to those of Aβ 1-40 alone infused AD control rats. The levels LPO also decreased both in the cerebral cortex 
Effects of S. cumini Administration on the Levels of Aβ1-40 in the Brains of AD Model Rats
The levels of Aβ peptide , as determined by indirect ELISA, significantly decreased in the detergent-insoluble fraction (DIF) of cortex (~18%) and hippocampus (>20%) homogenates of (Aβ 1-40 + S. cumini) rats. This suggest that S. cumini extract, by somehow decreased the amyloid burden in the brains of Alzheimer's disease model rats ( Figure 6 ). the detergent-insoluble membrane fractions (DIF) of cortex and hippocampus. DIF was prepared as described previously [38] . Each bar represents the mean ± SEM (n = 7 -8).
The data were analyzed by unpaired student's t-test. *P < 0.005.
Effects of S. cumini Administration on the Levels of Aβ1-40 Oligomers in the Brains of AD Model Rats
The relative levels of Aβ oligomers, the most toxic species of Aβ 1-40 also significantly decreased in the cortex of S. cumini-fed Alzheimer's disease (AD) model (Aβ 1-40 + S. cumini) rats (Figure 7 ). This suggests that the components in S. cumini might have reduced the brainamyloid Aβ burden by inhibiting at the stages of oligomer formation.
Effects of S. cumini on the TNFα, BDNF, TrKB, PSD-95, SNAP-25 of AD Model Rats
The oral administration of S. cumini decreased the levels of proinflammatory 
Effects of S. cumini Extract on the Fenton's Reagent-Induced Oxidative Stress of the Brain Tissues Homogenates (in Vitro Anti-LPO Effects)
The levels of LPO significantly incresed (>70%) in the homogenates of The data were analyzed by unpaired student's t-test.
*P < 0.005. represents the mean ± SEM (n = 7 -8). The data were analyzed by unpaired student's t-test. *P < 0.05.
of the control homogenate alone (Figure 9 ). However, if the oxidative stress was instigated in the presence of S. cumini, the levels of LPO were significantly suppressed (28% as compared to those of the control). This suggests that S. cumini extract significantly withstood the oxidative stress, as indicated by the reductions of the levels of LPO in the S. cumini-incubated brain homogenates (Figure 9 ). S. cumini alone also decreased the levels of LPO. Advances in Alzheimer's Disease 
In Vitro Free-Radical Scavenging Effects of S. cumini Seed Extract
The DPPH-scavenging activities of S. cumini seed extract versus BHT and quercetin are shown in the Figure 10 . The non-linear analyses revealed IC50 of 0.12 ± 0.03 mM, 0.014 ± 0.001 mM and 0.006 ± 0.0.001 mM GAE, respectively, for BHT, quercetin and the S. cumini seed extract (Figure 10(a) ). The seed extract or standards dose-dependently (0 -0.1 mM) decolorized the DPPH spots ( Figure   10(b) ). Therefore, the intensity, as evaluated by ImajeJ, of the DPPH spots gradually decreased with the concentrations of the extract and standards ( Figure   10(c) ). This indicates an anti-oxidative potential of the S. cumini extract.
Total Polyphenol and Flavonoid Contents of S. cumini Extract
We determined the total polyphenol/flavonoid contents of S. cumini seed extract. S. cumini seed contained 8.11 ± 0.10 μmol GAE/100 mg of dry powder.
Total flavonoid content was 2.3 ± 0.07 μmol QE/100 mg of dry powder.
Discussion
The aim of the present study was to investigate whether the chronic oral Alzheimer's brains. Aβ passes through diverse stages, including α-helix to β-sheet transformation, nucleation of β-sheet into oligomers, beading of oligomers into fibrills (fibrillation) and coalescence of fibrils into larger fibers, leading to matured amyloid aggregates [2] . These molecular transitions are typically associated with neuronal loss and cognitive deficits in AD. Therefore, the principal strategy for preventing AD is to inhibit the amyloid deposition in the brains of the AD patients. Although the accumulation of amyloid fibrous deposits is one of the important characteristic features of AD, the pathological significance of fibrillar plaques is still a matter of great debate [42] [43] . Rather, the levels of amyloid oligomers better correlate with the status of dementia in the AD patients [44] . Klyubin et al. (2005) [45] reported that oligomer decreases learning and memory by inhibiting the long-term potentiation. Oral administration of S. cumini extract decreased the amyloid burden in the brains of the AD model rats (Figure 6 ), however, the mechanism through which S. cumini decreased the amyloid burden from the AD rats remains to be known clearly. We speculate The increases in the oxidative stress, as indicated by the increased levels of lipid peroxide, are attributed to the neurodegenerative loss of neurons and related cognitive loss in the Alzheimers's disease [46] [47]. In our investigation, the memory-deficits in the AD rats were also associated with increases in the levels of LPO both in the plasma and brain cortico-hippocampal tissues ( Figure   5 ). The oral administration of S. cumini significantly reduced the levels of LPO both in the plasma and brain tissues ( Figure 5 ). Therefore it is conceiveable that S. cumini-induced decreases in the oxidative stress contributed to the amelioration of the cognitive deficits of AD model rats. The speculation is consistrent with the in vitro anti-LPO effect, DPPH-free radical scavenging effect, concurrently with the presence of subtantial amounts of total polyphenols/flavonoids in the extract of S. cumini seeds.
Neurodegeneration of Alzheimer's disease is also characterized by inflammation in the brain. Pathophysiology and associated inflammation of the AD brain thus might help to elucidate potential therapeutic and preventative options [48] . Neuro-inflammation driven by glial activation contributes to the damage of neurons [49] . These reports are well consistent with the increased levels of TNFα in the AD model rats of the present study. Whatever the mechanism is, our results provide a clear evidence that the induction of AD through ventricular infusion of Aβ in the rat brains resulted in an increase of the level of proinflammatory TNFα. Furthermore, the prescription of non-steroidal anti-inflmmatory (NSAID) drugs have been shown to benefit the AD symptoms [50] [51] . S. cumini-induced of the SNARE complex, is linked to the triggering of calcium-mediated exocytosis [57] and plays an important role in presynaptic neuro-transmitter release [58] .
The levels of SNAP-25 proteins also decreased in the brains of the AD model rats.
Therefore, the reductions in the levels of both PSD-95 and SNAP-25 proteins might affect the release and synaptic transmission to the postsynaptic neurons in the brains of the AD rats. The increased levels of PSD95 and SNAP-25 are thus consistent with the positive effects of S. cumini extract on the neurotransmitter packaging/release/synaptic connectivity, and finally on amelioration of memory S. cumini-fed AD rats.
Conclusion
The oral administration of S. cumini seed extract significantly ameliorated the concluded that S. cumini could be used as prophylaxis in the neurodegenerative diseases, such as Alzheimer's disease. However, the exact mechanism of action(s) of S. cumini extract on the BDNF, TrKB, PSD-95 and SNAP-25 proteins remains to be investigated. Thus, further experimentation is a must.
